|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
Executive Committee: Mapi Pharma Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Ehud Marom
CEO | Chief Executive Officer | 75 | 2007-12-31 |
Nir Bernstein
DFI | Director of Finance/CFO | 59 | 2013-10-31 |
Laura Popper
CTO | Chief Tech/Sci/R&D Officer | - | - |
Shai Rubnov
CTO | Chief Tech/Sci/R&D Officer | 53 | 2008-12-31 |
Alex Mogle
PRN | Corporate Officer/Principal | 58 | 2012-05-31 |
Composition of the Board of Directors: Mapi Pharma Ltd
| Director | Title | Age | Since |
|---|---|---|---|
Ehud Marom
CHM | Chairman | 75 | 2007-12-31 |
Itamar Borowitz
BRD | Director/Board Member | 82 | 2009-04-30 |
Alex Mogle
BRD | Director/Board Member | 58 | 2012-05-31 |
Dov Pekelman
BRD | Director/Board Member | 86 | - |
Itay Attar
BRD | Director/Board Member | - | - |
Uri Yaron
BRD | Director/Board Member | - | - |
Company details: Mapi Pharma Ltd
Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.02% | +1.26% | +41.37% | +105.18% | 69.19B | |
| -2.19% | -5.97% | +29.72% | +72.22% | 62.97B | |
| -1.11% | +2.78% | -14.86% | +375.59% | 27.27B | |
| -4.92% | -3.22% | -3.90% | -17.87% | 24.78B | |
| -0.93% | -0.81% | +29.69% | +14.38% | 25.8B | |
| -1.34% | -1.79% | +21.43% | -17.59% | 20.11B | |
| +6.04% | +7.25% | +233.25% | +383.12% | 18.47B | |
| -1.43% | -2.43% | -8.12% | +515.88% | 14.88B | |
| -2.27% | +1.37% | +53.01% | +160.83% | 14.29B | |
| Average | -0.68% | +0.74% | +42.40% | +176.86% | 30.86B | |
| Weighted average by Cap. | -0.51% | +0.11% | +37.35% | +139.30% |
- Stock Market
- Stocks
- Stock
- Company Mapi Pharma Ltd
Select your edition
All financial news and data tailored to specific country editions
